Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

H.M. Lokhorst; P. Sonneveld; J.J. Cornelissen; P. Joosten; M. van Marwijk Kooy; J. Meinema; H.K. Nieuwenhuis; M.H.J. van Oers; D.J. Richel; C.N. Segeren; G. Veth; L.F. Verdonck; P.W. Wijermans

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

H.M. Lokhorst, P. Sonneveld, J.J. Cornelissen, P. Joosten, M. van Marwijk Kooy, J. Meinema, H.K. Nieuwenhuis, M.H.J. van Oers, D.J. Richel, C.N. Segeren, G. Veth, L.F. Verdonck, P.W. Wijermans

Utrecht University

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	317-322
Number of pages	6
Journal	Bone Marrow Transplantation
Volume	23
Publication status	Published - 1999

Cite this

Lokhorst, H. M., Sonneveld, P., Cornelissen, J. J., Joosten, P., van Marwijk Kooy, M., Meinema, J., Nieuwenhuis, H. K., van Oers, M. H. J., Richel, D. J., Segeren, C. N., Veth, G., Verdonck, L. F., & Wijermans, P. W. (1999). Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma. Bone Marrow Transplantation, 23, 317-322.

@article{16c4b7eb7ef24794b582078517944c6c,

title = "Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma",

author = "H.M. Lokhorst and P. Sonneveld and J.J. Cornelissen and P. Joosten and {van Marwijk Kooy}, M. and J. Meinema and H.K. Nieuwenhuis and {van Oers}, M.H.J. and D.J. Richel and C.N. Segeren and G. Veth and L.F. Verdonck and P.W. Wijermans",

year = "1999",

language = "Undefined/Unknown",

volume = "23",

pages = "317--322",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

}

Lokhorst, HM, Sonneveld, P, Cornelissen, JJ, Joosten, P, van Marwijk Kooy, M, Meinema, J, Nieuwenhuis, HK, van Oers, MHJ, Richel, DJ, Segeren, CN, Veth, G, Verdonck, LF & Wijermans, PW 1999, 'Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma', Bone Marrow Transplantation, vol. 23, pp. 317-322.

Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma. / Lokhorst, H.M.; Sonneveld, P.; Cornelissen, J.J. et al.
In: Bone Marrow Transplantation, Vol. 23, 1999, p. 317-322.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma

AU - Lokhorst, H.M.

AU - Sonneveld, P.

AU - Cornelissen, J.J.

AU - Joosten, P.

AU - van Marwijk Kooy, M.

AU - Meinema, J.

AU - Nieuwenhuis, H.K.

AU - van Oers, M.H.J.

AU - Richel, D.J.

AU - Segeren, C.N.

AU - Veth, G.

AU - Verdonck, L.F.

AU - Wijermans, P.W.

PY - 1999

Y1 - 1999

M3 - Article

SN - 0268-3369

VL - 23

SP - 317

EP - 322

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

ER -